This study will compare the efficacy and safety of crisaborole ointment with tacrolimus ointment, in the treatment of patients with mild-to-moderate atopic dermatitis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
30
compare the efficacy and safety of crisaborole ointment on mild to moderate atopic dermatitis for 1 month and followup in 2 months
compare the efficacy and safety of tacrolimus ointment, in the treatment of patients with mild-to-moderate atopic dermatitis
Improvement of Investigator's Static Global Assessment score
1. Assessment of the \*\*Investigator's Static Global Assessment\*\* scores before and after treatment with crisaborole 2% ointment. 2. Assessment of the \*\*Investigator's Static Global Assessment\*\* before and after treatment with tacrolimus 0.03% ointment. 3. Comparison of the \*\*percentage of improvement\*\* in the \*\*Investigator's Static Global Assessment\*\* between the two treatment groups.
Time frame: 3 months
Improvement of Eczema Area and Severity Index
1. Assessment of \*\*Eczema Area and Severity Index\*\* scores before and after the use of \*\*crisaborole 2% ointment\*\*. 2. Assessment of \*\*Eczema Area and Severity Index\*\* scores before and after the use of \*\*tacrolimus 0.03% ointment\*\*. 3. Comparison of the percentage of improvement in the \*\*Eczema Area and Severity Index\*\* scores between the two treatment groups
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.